更多...
收起
This gene encodes a member of the SFRP family that contains a cysteine-rich domain homologous to the putative Wnt-binding site of Frizzled proteins. SFRPs act as soluble modulators of Wnt signaling. Methylation of this gene is a potential marker for the presence of colorectal cancer. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  这个基因编码包含富含半胱氨酸的结构域同源的卷曲蛋白的推定的Wnt结合位点的SFRP家族的一个成员。的SFR P充当Wnt信号传导的可溶性调节剂。该基因的甲基化是结肠直肠癌的存在的潜在标记物。 [由RefSeq的,2008年7月提供]
SFRP2基因(以及对应的蛋白质)的细胞分布位置:
SFRP2基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Colorectal Neoplasms | 0.131168843 | 7 | 0 | BeFree_CTD_human_LHGDN |
Renal Cell Carcinoma | 0.123538676 | 3 | 0 | BeFree_CTD_human_LHGDN |
Inflammatory Bowel Diseases | 0.120542884 | 2 | 0 | BeFree_CTD_human |
Mammary Neoplasms | 0.120542884 | 2 | 0 | BeFree_CTD_human |
Myocardial Infarction | 0.08 | 0 | 0 | RGD |
Myocardial Reperfusion Injury | 0.08 | 0 | 0 | RGD |
Colorectal Cancer | 0.008262808 | 15 | 0 | BeFree_GAD |
Adenoma | 0.003810118 | 4 | 0 | BeFree_LHGDN |
Colorectal Carcinoma | 0.003528744 | 13 | 0 | BeFree |
Bladder Neoplasm | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Squamous cell carcinoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Liver neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Pancreatic Neoplasm | 0.00272435 | 1 | 0 | LHGDN |
Pituitary Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
ovarian neoplasm | 0.00272435 | 1 | 0 | LHGDN |
Albuminuria | 0.002367032 | 1 | 1 | GAD |
Asthma | 0.002367032 | 1 | 0 | GAD |
Left Ventricular Hypertrophy | 0.002367032 | 1 | 0 | GAD |
Carcinogenesis | 0.002171535 | 8 | 0 | BeFree |
Malignant neoplasm of breast | 0.001085767 | 4 | 0 | BeFree |
Breast Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Leukemia, Myelocytic, Acute | 0.000814326 | 3 | 0 | BeFree |
Hyperplastic Polyp | 0.000814326 | 3 | 0 | BeFree |
Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Malignant tumor of cervix | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of stomach | 0.000542884 | 2 | 0 | BeFree |
Multiple Myeloma | 0.000542884 | 2 | 0 | BeFree |
Retinitis Pigmentosa | 0.000542884 | 2 | 0 | BeFree |
Cicatrix, Hypertrophic | 0.000542884 | 2 | 0 | BeFree |
Adenomatous Polyps | 0.000542884 | 2 | 0 | BeFree |
Cervix carcinoma | 0.000542884 | 2 | 0 | BeFree |
Stomach Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Adenoma of large intestine | 0.000542884 | 2 | 0 | BeFree |
Bone Diseases | 0.000271442 | 1 | 0 | BeFree |
Ulcerative Colitis | 0.000271442 | 1 | 0 | BeFree |
Gastrointestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
Keloid | 0.000271442 | 1 | 0 | BeFree |
Chronic Lymphocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Medulloblastoma | 0.000271442 | 1 | 0 | BeFree |
Parathyroid Neoplasms | 0.000271442 | 1 | 0 | BeFree |
polyps | 0.000271442 | 1 | 0 | BeFree |
Rectal polyp | 0.000271442 | 1 | 0 | BeFree |
Oral Cavity Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Tumor Progression | 0.000271442 | 1 | 0 | BeFree |
Lip and Oral Cavity Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cervical Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Solid tumour | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma in Situ | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of prostate | 0.000271442 | 1 | 0 | BeFree |
Malignant Glioma | 0.000271442 | 1 | 0 | BeFree |
Prostate carcinoma | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of kidney | 0.000271442 | 1 | 0 | BeFree |
precancerous lesions | 0.000271442 | 1 | 0 | BeFree |
High-Grade Prostatic Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Basaloid squamous cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
Esophageal Basaloid Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Renal carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cancer Cell Growth | 0.000271442 | 1 | 0 | BeFree |
Non-Neoplastic Disorder | 0.000271442 | 1 | 0 | BeFree |
Intracranial glioma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。